BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 379641)

  • 21. Objective monitoring of graft-versus-host disease: alpha 1-antichymotrypsin concentration changes after bone marrow transplantation in patients developing graft-versus-host reactions.
    Kamiguchi H; Ohkubo T; Yamamura M; Katsunuma T
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):165-8. PubMed ID: 3914740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Graft-versus-host reaction as a complication of bone marrow transplantation].
    Bogdanić V; Dobrić I; Labar B
    Lijec Vjesn; 1984 Jun; 106(6):238-40. PubMed ID: 6381946
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms and avoidance of graft-versus-host disease.
    van Bekkum DW; Wagemaker G; Vriesendorp HM
    Transplant Proc; 1979 Mar; 11(1):189-95. PubMed ID: 377629
    [No Abstract]   [Full Text] [Related]  

  • 24. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
    Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute graft-versus-host disease in allogeneic bone marrow transplantation].
    Harada M; Funada H; Yoshida T; Kodo H; Mori T; Matsue K; Shiobara S; Ohtake S; Odaka K; Teshima H
    Rinsho Ketsueki; 1984 Jul; 25(7):1043-51. PubMed ID: 6389930
    [No Abstract]   [Full Text] [Related]  

  • 26. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
    Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
    Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes of hemopoiesis in a child with aplastic anemia effectively treated by syngeneic bone marrow transplantation].
    Tsuji K; Naganuma K; Yagi Y; Norose N; Koike K; Saitoh H; Akabane T; Ogata H
    Rinsho Ketsueki; 1982 Oct; 23(10):1594-9. PubMed ID: 6759698
    [No Abstract]   [Full Text] [Related]  

  • 28. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
    Butturini A; Bortin MM; Seeger RC; Gale RP
    Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplants in ALL.
    Barrett AJ; Horowitz MM
    Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Graft versus host disease. Analysis of 131 cases of bone marrow transplant].
    Rozman C; Grañena A; Carreras E; Marín P; Martín E; Palou J; Mascaró JM; Bruguera M
    Med Clin (Barc); 1987 Jun; 89(3):89-94. PubMed ID: 3306189
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation in patients with leukemia. Incidence and severity of graft-versus-host disease in successful HL-A-matched transplants.
    Graw RG; Santos GW
    Transplantation; 1971 Feb; 11(2):197-9. PubMed ID: 4397090
    [No Abstract]   [Full Text] [Related]  

  • 34. [Occurrence and therapy of conjunctival changes in graft versus host reaction following bone marrow transplantation].
    Giovannini A; Amatetti S; Carloni S
    Fortschr Ophthalmol; 1986; 83(1):70-1. PubMed ID: 3519397
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation.
    Pawelec G; Ehninger G; Schmidt H; Wernet P
    Transplantation; 1986 Nov; 42(5):558-60. PubMed ID: 3538541
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine and graft-versus-host disease after bone marrow transplantation.
    N Engl J Med; 1988 Dec; 319(24):1607-8. PubMed ID: 3059188
    [No Abstract]   [Full Text] [Related]  

  • 37. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of the gut flora on graft versus host disease (GvHD) following allogeneic bone marrow transplantation--experimental observations and possible mechanisms.
    Faulkner L; Rapson N; Moore R; Cohen J
    Prog Clin Biol Res; 1988; 272():195-206. PubMed ID: 3293077
    [No Abstract]   [Full Text] [Related]  

  • 40. Age-related factors in the induction of syngeneic GVHD.
    Fischer AC; Beschorner WE; Hess AD
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3033-5. PubMed ID: 2650419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.